全文获取类型
收费全文 | 396439篇 |
免费 | 17986篇 |
国内免费 | 412篇 |
专业分类
耳鼻咽喉 | 4974篇 |
儿科学 | 13764篇 |
妇产科学 | 11762篇 |
基础医学 | 57069篇 |
口腔科学 | 8057篇 |
临床医学 | 30342篇 |
内科学 | 76102篇 |
皮肤病学 | 6781篇 |
神经病学 | 31016篇 |
特种医学 | 16137篇 |
外国民族医学 | 43篇 |
外科学 | 64315篇 |
综合类 | 8535篇 |
现状与发展 | 1篇 |
一般理论 | 160篇 |
预防医学 | 29099篇 |
眼科学 | 7947篇 |
药学 | 26019篇 |
中国医学 | 791篇 |
肿瘤学 | 21923篇 |
出版年
2018年 | 15128篇 |
2017年 | 12081篇 |
2016年 | 14386篇 |
2015年 | 3885篇 |
2014年 | 4876篇 |
2013年 | 7478篇 |
2012年 | 12206篇 |
2011年 | 19675篇 |
2010年 | 14217篇 |
2009年 | 11604篇 |
2008年 | 19424篇 |
2007年 | 22787篇 |
2006年 | 9580篇 |
2005年 | 11090篇 |
2004年 | 11330篇 |
2003年 | 12242篇 |
2002年 | 10498篇 |
2001年 | 13639篇 |
2000年 | 14198篇 |
1999年 | 11629篇 |
1998年 | 3226篇 |
1997年 | 3061篇 |
1996年 | 2799篇 |
1995年 | 2711篇 |
1994年 | 2529篇 |
1993年 | 2359篇 |
1992年 | 8451篇 |
1991年 | 8598篇 |
1990年 | 8402篇 |
1989年 | 8203篇 |
1988年 | 7423篇 |
1987年 | 7208篇 |
1986年 | 6832篇 |
1985年 | 6628篇 |
1984年 | 4838篇 |
1983年 | 4193篇 |
1982年 | 2563篇 |
1979年 | 4527篇 |
1978年 | 3297篇 |
1977年 | 2752篇 |
1976年 | 2575篇 |
1975年 | 2834篇 |
1974年 | 3388篇 |
1973年 | 3373篇 |
1972年 | 3118篇 |
1971年 | 2948篇 |
1970年 | 2861篇 |
1969年 | 2617篇 |
1968年 | 2559篇 |
1967年 | 2373篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
Edward J. Holland Walter O. Whitley Kenneth Sall Stephen S. Lane Aparna Raychaudhuri Steven Y. Zhang 《Current medical research and opinion》2016,32(10):1759-1765
Objective: Report efficacy findings from three clinical trials (one phase 2 and two phase 3 [OPUS-1, OPUS-2]) of lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease (DED).Research design and methods: Three 84-day, randomized, double-masked, placebo-controlled trials. Adults (≥18 years) with DED were randomized (1:1) to lifitegrast 5.0% or matching placebo. Changes from baseline to day 84 in signs and symptoms of DED were analyzed.Main outcome measures: Phase 2, pre-specified endpoint: inferior corneal staining score (ICSS; 0–4); OPUS-1, coprimary endpoints: ICSS and visual-related function subscale (0–4 scale); OPUS-2, coprimary endpoints: ICSS and eye dryness score (EDS, VAS; 0–100).Results: Fifty-eight participants were randomized to lifitegrast 5.0% and 58 to placebo in the phase 2 trial; 293 to lifitegrast and 295 to placebo in OPUS-1; 358 to lifitegrast and 360 to placebo in OPUS-2. In participants with mild-to-moderate baseline DED symptomatology, lifitegrast improved ICSS versus placebo in the phase 2 study (treatment effect, 0.35; 95% CI, 0.05–0.65; p?=?0.0209) and OPUS-1 (effect, 0.24; 95% CI, 0.10–0.38; p?=?0.0007). Among more symptomatic participants (baseline EDS ≥40, recent artificial tear use), lifitegrast improved EDS versus placebo in a post hoc analysis of OPUS-1 (effect, 13.34; 95% CI, 2.35–24.33; nominal p?=?0.0178) and in OPUS-2 (effect, 12.61; 95% CI, 8.51–16.70; p?<?0.0001).Limitations: Trials were conducted over 12 weeks; efficacy beyond this period was not assessed.Conclusions: Across three trials, lifitegrast improved ICSS in participants with mild-to-moderate baseline symptomatology in two studies, and EDS in participants with moderate-to-severe baseline symptomatology in two studies. Based on the overall findings from these trials, lifitegrast shows promise as a new treatment option for signs and symptoms of DED. 相似文献
22.
23.
24.
25.
N. S. Hari Narayana Moorthy Sergio F. Sousa Maria J. Ramos Pedro A. Fernandes 《Medicinal chemistry research》2016,25(7):1340-1357
Farnesyltransferase (FTase) is one of the prenyltransferase family enzymes that catalyse the transfer of 15-membered isoprenoid (farnesyl) moiety to the cysteine of CAAX motif-containing proteins including Rho and Ras family of G proteins. Inhibitors of FTase act as drugs for cancer, malaria, progeria and other diseases. In the present investigation, we have developed two structure-based pharmacophore models from protein–ligand complex (3E33 and 3E37) obtained from the protein data bank. Molecular dynamics (MD) simulations were performed on the complexes, and different conformers of the same complex were generated. These conformers were undergone protein–ligand interaction fingerprint (PLIF) analysis, and the fingerprint bits have been used for structure-based pharmacophore model development. The PLIF results showed that Lys164, Tyr166, TrpB106 and TyrB361 are the major interacting residues in both the complexes. The RMSD and RMSF analyses on the MD-simulated systems showed that the absence of FPP in the complex 3E37 has significant effect in the conformational changes of the ligands. During this conformational change, some interactions between the protein and the ligands are lost, but regained after some simulations (after 2 ns). The structure-based pharmacophore models showed that the hydrophobic and acceptor contours are predominantly present in the models. The pharmacophore models were validated using reference compounds, which significantly identified as HITs with smaller RMSD values. The developed structure-based pharmacophore models are significant, and the methodology used in this study is novel from the existing methods (the original X-ray crystallographic coordination of the ligands is used for the model building). In our study, along with the original coordination of the ligand, different conformers of the same complex (protein–ligand) are used. It concluded that the developed methodology is significant for the virtual screening of novel molecules on different targets. 相似文献
26.
27.
Characteristics of hyperparathyroid states in the Canadian multicentre osteoporosis study (CaMos) and relationship to skeletal markers 下载免费PDF全文
28.
29.
We report a case of intestinal obstruction in a 73-year-old woman caused by ileocolic intussusception. The underlying cause was a giant submucosal ulcerating lipoma (6?×?3.3?×?3.8 cm) extending from the superior mucosal lip of Bauhin’s valve. Abdominal ultrasonography showed a pathognomonic target-like mass appearing as multiple concentric rings. CT scan confirmed the diagnosis. Because of apparent obstruction, a laparotomy with right hemicolectomy and ileocolic anastomosis was performed. Lipomas most frequently occur in the cecum and ascending colon where they represent the most common submucosal mesenchymal tumor. They typically occur in elderly women with an incidence that varies from 0.15 to 0.56 %. Pain, rectal bleeding, and obstruction are typical symptoms. When faced with an intussusception in children, reduction with air per rectum can be performed. In adults, however, malignant cell spreading and seeding is of big concern. Since approximately 20–50 % of all underlying causes are malignant, explorative surgery is favored in adults. 相似文献